Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
Clinical trial NCT02768558 · TERMINATED
Trial details
- NCT number
- NCT02768558
- Sponsor
- RTOG Foundation, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-17
- Primary completion
- 2019-01-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.